PMID: 11921428Mar 29, 2002Paper

The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System

Diabetes/metabolism Research and Reviews
Pankaj ModiAndrew Lewin

Abstract

The inability of subcutaneous (sc) insulin to effectively, safely and painlessly control postprandial glucose levels has encouraged the exploration of alternate methods of insulin delivery. Recently, a novel drug delivery system, based on a unique liquid aerosol formulation, has been developed. This system allows precise insulin dose delivery via a simple, cosmetically acceptable metered dose inhaler in the form of fine aerosolized droplets directed into the mouth. The system introduces a fine-particle aerosol at high velocity into the patient's breath; the mouth deposition is dramatically increased compared with conventional technology. This oral aerosol formulation is rapidly absorbed through the buccal mucosal lining and in the oropharynx regions, and it provides the plasma insulin levels necessary to control postprandial glucose rise in diabetic patients. This novel, pain-free, oral insulin formulation has a critical series of attributes: rapid absorption, a simple (user-friendly) administration technique, precise dosing control (comparable to injection within one unit), and bolus delivery of drug. This review describes the recent results of clinical studies (in type 1 and type 2 diabetic patients) by comparing the efficacy...Continue Reading

Citations

Apr 6, 2004·Advanced Drug Delivery Reviews·David J Brayden, Alan W Baird
Jun 1, 2005·Archives of Medical Research·Francisco J Gómez-Pérez, Juan A Rull
Nov 20, 2003·Trends in Biotechnology·Samantha Lien, Henry B Lowman
Dec 1, 2010·Diabetes, Obesity & Metabolism·A PalermoP Pozzilli
Apr 6, 2006·AAPS PharmSciTech·Abeer M Al-GhananeemPeter A Crooks
May 1, 2008·Indian Journal of Pharmaceutical Sciences·M M Al-Tabakha, A I Arida
Mar 13, 2014·Drug Development and Industrial Pharmacy·Javier O Morales, Jason T McConville
Dec 22, 2007·Expert Opinion on Drug Delivery·Christiane DamgéPhilippe Maincent
May 24, 2007·Drug Development and Industrial Pharmacy·Abeer M Al-GhananeemPeter A Crooks
Aug 30, 2008·Expert Opinion on Drug Delivery·Gerald Bernstein
Mar 7, 2008·Expert Opinion on Emerging Drugs·Pritish K Tosh, Gregory A Poland
Aug 21, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mayura Oak, Jagdish Singh
Mar 5, 2011·Advanced Drug Delivery Reviews·Vanessa HearndenMartin H Thornhill
Aug 17, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amnon C SintovShafir Botner
Dec 15, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Caslin A GilroyAshutosh Chilkoti
Dec 15, 2015·Canadian Journal of Diabetes·Kitty Kit Ting Cheung, Peter Alexander
Jun 17, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Nicholas A Peppas, Nikhil J Kavimandan
Nov 25, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·D R OwensG Bolli
May 26, 2004·International Journal of Pharmaceutics·T MorçölS J D Bell
Apr 1, 2005·Drug Discovery Today. Technologies·Silvia RossiCarla M Caramella
Jul 1, 2005·Metabolism: Clinical and Experimental·Paolo PozzilliPankaj Modi
Nov 22, 2005·Expert Opinion on Drug Delivery·Isabel Gomez-Orellana
Apr 23, 2015·International Journal of Pharmaceutics·Heba Abd El AzimNawal Khalafallah
Oct 12, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vivek K PawarManish K Chourasia
Mar 5, 2003·Journal of Biomaterials Applications·N K Kavitha Raj, Chandra P Sharma
Feb 11, 2010·Journal of Diabetes Science and Technology·Lutz Heinemann, Yves Jacques
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Pamela RoyleSam Philip
Jan 8, 2019·Macromolecular Bioscience·Zahra Baghban TaraghdariFatemeh Mohabatpour
Apr 2, 2003·Nature Reviews. Drug Discovery·Michael Goldberg, Isabel Gomez-Orellana
Nov 4, 2009·Pharmaceutical Development and Technology·Deshika ReddyLisa C du Toit
Nov 9, 2018·Frontiers in Endocrinology·Ignazio VecchioMariano Martini
Oct 25, 2002·Diabetes/metabolism Research and Reviews
Jan 1, 2014·Journal of Pharmaceutics·Arun VermaPramod Kumar Sharma
Mar 1, 2006·AAPS PharmSciTech·Abeer M Al-GhananeemPeter A Crooks
Aug 21, 2007·Diabetes Technology & Therapeutics·Jaime Guevara-AguirreArlan L Rosenbloom
Sep 19, 2019·International Journal of Pharmaceutics·Phuong H L TranThao T D Tran
Feb 2, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·David J Brayden, Vivien Stuettgen
May 31, 2021·Advanced Drug Delivery Reviews·Zhi LuoJean-Christophe Leroux
Dec 14, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Izumi Takei, Tomohiro Kasatani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.